In vivo experiments have demonstrated that circulating levels of diet-induced IGF1 was correlated with tumor progression and EMT in a murine model of luminal breast cancer [105], and diet-induced obesity promoted tumor progression and EMT in murine models of breast cancer [106]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.